Abeona Therapeutics (ABEO) Interest Coverage Ratio (2011 - 2026)
Abeona Therapeutics' (ABEO) quarterly Interest Coverage Ratio came in at 16.97 in Q1 2026, down 17.36% year-on-year from 20.54 in Q1 2025, and down 173.2% quarter-over-quarter from 23.19 in Q4 2025.
Abeona Therapeutics (ABEO) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
Abeona Therapeutics' Interest Coverage Ratio history runs 16 years deep, the most recent figure standing at 16.97 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio fell 17.36% year-over-year to 16.97 in Q1 2026; TTM through Mar 2026 was 68.35, a 33.94% decrease from a year earlier, with the FY2025 full-year figure at 1.19, up 92.18% from the prior year.
- Interest Coverage Ratio declined to 16.97 in Q1 2026 per ABEO's latest filing, from 23.19 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 23.19 in Q4 2025 and bottomed at 121.18 in Q4 2023.
- The 5-year median for Interest Coverage Ratio is 9.89 (2024), against an average of 17.8.
- Across the five-year window, Interest Coverage Ratio sank 1680.29% in 2023 and soared 250.5% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 72.67 in 2022, then sank by 66.75% to 121.18 in 2023, then surged by 87.28% to 15.41 in 2024, then soared by 250.5% to 23.19 in 2025, then plunged by 173.2% to 16.97 in 2026.
- Per Business Quant, the three latest ABEO Interest Coverage Ratio figures stand at 16.97 (Q1 2026), 23.19 (Q4 2025), and 16.83 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Abeona Therapeutics | 107.85 Mn | -60.42 Mn | 6.02 Mn | -16.97 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.97 |
| Dec 31, 2025 | 23.19 |
| Sep 30, 2025 | -16.83 |
| Jun 30, 2025 | -17.15 |
| Mar 31, 2025 | -14.46 |
| Dec 31, 2024 | -15.41 |
| Sep 30, 2024 | -2.83 |
| Jun 30, 2024 | -9.89 |
| Mar 31, 2024 | -7.18 |
| Dec 31, 2023 | -121.18 |
| Sep 30, 2023 | -8.27 |
| Jun 30, 2023 | -13.34 |
| Mar 31, 2023 | -1.35 |
| Dec 31, 2022 | -72.67 |
| Sep 30, 2022 | -5.75 |
| Jun 30, 2022 | -0.75 |
| Mar 31, 2022 | -1.79 |
| Dec 31, 2021 | 14.57 |
| Sep 30, 2021 | -16.24 |
| Jun 30, 2021 | -9.14 |